I would change the order of your priorities, Hy.
Post# of 36536
(Total Views: 257)
Posted On: 03/03/2020 4:39:35 PM
I would change the order of your priorities, Hy.
1) They need to get the NGIO spin publicized/moving. Or an Excellagen licensing deal signed ($10MM).
2) They need to get the S-1 approved.
If the S-1 is approved, and we're under $1, Joe really doesn't have access to the capital. So we really need something to move the needle before Joe can put the pedal down.
Also, I wouldn't say the vaccine news has been completely a flash in the pan... yet. Don't forget we were trading at .57ish before the China PR came out. So even at .87, we are significantly higher. Of course, it remains to be seen how long that will last with no news.
NGIO deets, please...
1) They need to get the NGIO spin publicized/moving. Or an Excellagen licensing deal signed ($10MM).
2) They need to get the S-1 approved.
If the S-1 is approved, and we're under $1, Joe really doesn't have access to the capital. So we really need something to move the needle before Joe can put the pedal down.
Also, I wouldn't say the vaccine news has been completely a flash in the pan... yet. Don't forget we were trading at .57ish before the China PR came out. So even at .87, we are significantly higher. Of course, it remains to be seen how long that will last with no news.
NGIO deets, please...
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼